Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Barr Submits Plan B Response To FDA, Starts 180-Day Review Clock

Jul 22 2004

• By Karl Uhlendorf

Related Content

Dual Status Rx/OTC Plan B In The Works? Barr Weighs Its Options

May 20 2004

Plan B OTC Submission Deemed "Not Approvable"

May 06 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window